DESFERRIOXAMINE INFUSIONS IN THALASSEMIA MAJOR

被引：0

作者：

MATTHEWS, RN

EKERT, H

MCKAY, MRG

机构：

[1] ROYAL CHILDRENS HOSP,DEPT CLIN HAEMATOL & ONCOL,PARKVILLE 3052,VICTORIA,AUSTRALIA

[2] ROYAL CHILDRENS HOSP,DEPT CLIN BIOCHEM,PARKVILLE 3052,VICTORIA,AUSTRALIA

来源：

AUSTRALIAN PAEDIATRIC JOURNAL | 1978年 / 14卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R72 [儿科学];

学科分类号：

100202 ;

摘要：

引用

页码：292 / 292

页数：1

共 50 条

[31] OPTIMAL USE OF DESFERRIOXAMINE IN THE TREATMENT OF THALASSEMIA
KATTAMIS, C
IRON OVERLOAD AND CHELATION IN THALASSAEMIA, 1989, : 11 - 25
[32] LONGITUDINAL GROWTH OF PATIENTS WITH THALASSEMIA MAJOR (HOMOZYGOUS BETA-THALASSEMIA) DURING CONTINUOUS SUBCUTANEOUS INFUSIONS OF DEFEROXAMINE
KRUGER, N
STUBBE, P
TILLMANN, W
SCHROTER, W
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1986, 111 (05) : 176 - 181
[33] Regression of myocardial dysfunction after switching from desferrioxamine to deferiprone therapy in β-thalassemia major patients
Huang, Yu-Chih
Chang, Jeng-Sheng
Wu, Kang-Hsi
Peng, Ching-Tien
HEMOGLOBIN, 2006, 30 (02) : 229 - 238
[34] ASCORBIC-ACID ENHANCEMENT OF DESFERRIOXAMINE-INDUCED URINARY IRON EXCRETION IN THALASSEMIA MAJOR
OBRIEN, RT
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1974, 232 (MAY24) : 221 - 225
[35] Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major
K. H. Wu
J. S. Chang
C. H. Tsai
C. T. Peng
Annals of Hematology, 2004, 83 : 471 - 473
[36] CONTINUOUS SUBCUTANEOUS DESFERRIOXAMINE INFUSIONS IN PATIENTS WITH HEMOSIDEROSIS
TILLMANN, W
KONIG, R
SCHRODER, K
SCHROTER, W
MONATSSCHRIFT KINDERHEILKUNDE, 1982, 130 (03) : 171 - 172
[37] Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with β-thalassemia major
Wu, KH
Chang, JS
Tsai, CH
Peng, CT
ANNALS OF HEMATOLOGY, 2004, 83 (07) : 471 - 473
[38] Liver histological findings in adult thalassemia major patients under regular chelation therapy with desferrioxamine.
Cappellini, MD
Zatelli, S
Cerino, M
Fargion, S
Sampietro, M
Zanaboni, L
Fiorelli, G
HEPATOLOGY, 1999, 30 (04) : 373A - 373A
[39] IRON CHELATION IN THALASSEMIA - MECHANISM OF DESFERRIOXAMINE ACTION
HERSHKO, C
RACHMILEWITZ, EA
ISRAEL JOURNAL OF MEDICAL SCIENCES, 1978, 14 (11): : 1111 - 1115
[40] COMPARISON OF LABILITY OF PLASMA NON-TRANSFERRIN BOUND IRON WITH DESFERRIOXAMINE THERAPY IN THALASSEMIA MAJOR AND INTERMEDIA
PORTER, JB
SINGH, S
ABEYSINGHE, RD
MARSHALL, L
HIDER, RC
BRITISH JOURNAL OF HAEMATOLOGY, 1993, 84 : 64 - 64

← 1 2 3 4 5 →